Sociodemographic Risk Factors for Depression in Patients With Chronic Liver Disease
Lucia Rivera‐Matos, Sarah Andrews, Sheila Eswaran – 26 May 2022
Early in his career, Oren K. Fix, MD, MSc attended an AASLD trainee workshop where he was urged to find a mentor.
"I didn’t really know what the word meant. But in medical school, I was randomly paired with a gastroenterologist who specialized in hepatology, Dr. Thomas Mahl. He was an inspiration to me. Most of us probably choose our specialty because of the people we meet early on who take us under their wing," he says. "This was a guy I wanted to be like. He loved the work he was doing with his patients. He was having fun doing it."
Dr. Fix, who was named a Fellow of the AASLD in 2017, earned his medical degree at State University of New York at Buffalo School of Medicine. He completed his Internal Medicine internship and residency, then a Gastroenterology fellowship and a Clinical Research Training (CREST) fellowship at Boston University School of Medicine. He now serves as Medical Director of the Liver Transplant Program at Seattle's Swedish Medical Center. His cross-country journey included training in medical education, clinical medicine, research, epidemiology and clinical informatics.
Second Chance At Life
As a GI fellow, Dr. Fix spent a month at Beth Israel Deaconess Medical Center to learn more about liver transplantation, then unavailable at Boston University. "Seeing patients who were at death's door receive a transplant and a second chance at life, I realized that I had to get involved in transplantation."
Both his program director, Dr. Robert Lowe, and his research mentor, Dr. David Nunes, encouraged him to earn a Master of Science degree in epidemiology from BU’s School of Public Health and pursue a CREST fellowship. "That set me on a path to work in academic hepatology. I didn’t plan on going into academics when I started medical school. I didn’t know what I wanted to be when I was in residency. I was like a sponge."
In 2005, he switched coasts to pursue a Transplant Hepatology Fellowship at the University of California, San Francisco. But he had to come up with his own funding, so he applied for the AASLD Advanced Hepatology Training Award.
"The training pathway I was seeking is now established and most programs have internal funding, but at the time, it was new and UCSF didn’t provide the funding. My mentor told me to apply for it, and I got it," he says. "Without the award from AASLD, I would not have been able to train at UCSF."
After a short stint at the University of Washington, he returned to UCSF to work in medical education, completing a two-year Teaching Scholars Program focused on educational research, curriculum design and leadership. He was also the Program Director for UCSF’s Transplant Hepatology Fellowship. "Something crystallized for me in that moment. It was the excitement of being a part of the next generation of doctors."
Trainee-Centered Education
As Chair of AASLD's Training and Workforce Committee, Dr. Fix led AASLD's pilot program for training hepatologists, which has long required three years of GI training followed by one year of transplant hepatology training.
"Some people have found that extra year of training to be a barrier to hepatology certification, and the three years of GI training to be excessive and not aligned with their ultimate career goals," he says. In 2012, the American Board of Internal Medicine (ABIM) invited applications for pilot programs that focused on competency, or outcomes-based training. The AASLD's proposed program incorporated transplant hepatology training in the third year of GI fellowship. Now in its eighth year, the program was recently approved by ABIM as a formal training pathway. "Pilot fellows are able to combine their GI and hepatology training into three years that's more trainee-centered and focused on their career goals," he says.
In addition to serving as Medical Director of Swedish's liver transplant program and as a member of the Internal Medicine Review Committee for the Accreditation Council for Graduate Medical Education (ACGME), Dr. Fix has a new passion: the emerging field of clinical informatics, an evolving field that applies data and information technology to patient care, and includes population health, clinical decision support and optimization of the electronic health record.
"EHRs can be so clunky, and many physicians hate interacting with them, in part because they’re not designed by us. So, let's get physicians more involved in the design and optimization process," says Dr. Fix, now a board-certified Clinical Informaticist and Epic-certified Physician Builder. "This is a new specialty that is still relatively uncharted for practicing clinicians. It's a glimpse into the future of patient care, as more and more patients are gaining access to their own health data, and large health systems see how the data can be used to improve the quality and skyrocketing cost of health care. I’m an outlier. I have embraced the EHR because I realize it's here to stay, but I want to make it better for physicians."
Dr. Fix and his wife, Amy, a cardiac intensive care nurse at Swedish, live in Seattle's Capitol Hill district with Frank, their 12-year-old chihuahua/terrier mix. They enjoy hiking, camping and snowboarding.
"Another thing we do together is the New York Times crossword puzzle. It's kind of a nerdy activity, but it's become a ritual for us. We love it."
Hepatology is a journey, says Vijay H. Shah, MD, a Fellow of AASLD since 2018 and the Chair of Gastroenterology and Hepatology Division at the Mayo Clinic Department of Internal Medicine in Rochester, Minnesota.
"The vision that inspires me is to develop a world where people don’t suffer from liver disease. That is a big vision. That’s the vision of the leaders at AASLD." Achieving that goal will take leaders with skills like careful listening, teamwork, delegating tasks, time management and compassion, which are not taught in medical school, he says.
"Successful leaders need different skills at different points in their career. Early on, trainees depend on grit. That’s how the medical system works. You succeed because you work hard, have a high IQ and achieve goals. But, as people reach mid-career, you realize that grit is not scalable. It’s at that point that you recognize the value of teamwork or ‘EQ,’ emotional intelligence. It’s the ability to work as a team and to inspire teams, that is more scalable. You mentor and inspire the team, and everyone benefits," he says.
Dr. Shah was inspired and guided by mentors throughout his career, starting with Peter Kahrilas, MD, of Northwestern University’s Feinberg School of Medicine, where Dr. Shah completed a combined six-year undergraduate and medical degree program, followed by his internal medicine residency. Another early influence was the late Andy Blei, MD, "who pointed me toward research in portal hypertension. I wanted to be just like him," he says. Dr. Shah completed a fellowship in digestive diseases at Yale University with mentors Roberto Grossman, MD and William C. Sessa, PhD. At Yale, he recognized the need to gain more molecular technology skills and sought that training.
As a trainee, Dr. Shah worked in inner-city hospitals where alcohol-related liver diseases were rampant. This inspired by many years of research on disease mechanisms in ARLDs, as well as identifying biomarkers that could translate to successful treatments.
"Patients were suffering with severe physical problems like encephalopathy, ascites and GI bleeding. They had coexisting psychological conditions. They had burned bridges with their families and lost social connections. Alcoholism bridges the physical, emotional and social aspects of health." At the time, most felt that little could be done for these patients, and there wasn’t much to study. "When we realized there was a genetic component to the disease, and that we can have a positive impact on people with treatments for substance abuse and for their physical disease, it all changed."
Despite the burden on so many patients’ lives, limited research funding was available. "It was really a mismatch. But at Mayo, we are exploring pathways for new drug development, and translational research through biospecimens, and a number of clinical trials are ongoing now. We’ve had success with specific molecules, and some potential treatments are very exciting, but more advanced trials are needed," he says. "Even with the potential blood biomarkers we have identified, we have to keep working to find better biomarkers and better treatments."
Dr. Shah embraces the role of "servant-leader," one who helps and inspires those around them, and by doing so, helps the organization as a whole. He learns leadership concepts from his wife, Pri Shah, PhD, who teaches organizational development and training at the University of Minnesota. "She’s taught me to focus on people. A common mistake is to focus on strategy, not people. Without engaged people on your team, your strategy will go nowhere."
Leadership does not require a title or years of experience, but the willingness to lead by example, he says. "The organizational chart doesn’t always match where people look for inspiration. At each step of my career where I’ve had to lead others – as the head of a care team, a laboratory team, as a chair or the chief of a division – I realized that some skills are universal. But you need so many new skills as you grow. Leadership is about learning. If you’re too busy, you’re probably doing the wrong things. We all need to ask ourselves, ‘Where am I spending my time?’ That’s what I discuss with our junior faculty."
The Shahs have two daughters, ages 20 and 17, and enjoy family skiing vacations. He plays guitar, and he’s jammed with Jonathan Dranoff, MD, also a Fellow of the AASLD. "I remember that when we were fellows, at our apartment in New Haven, Jon got on top of my living room coffee table and started playing guitar. My wife had questions!" Dr. Shah recalls. "I love all kinds of music, from opera to hard rock. When I’m exercising, I like to listen to hard rock. When I am contemplating, I listen to classical and opera."
During his internal medicine residency at Boston University and Boston City Hospital, Jonathan Dranoff, MD, already knew that he wanted to be a gastroenterologist. But his eventual career path included turns that he did not envision.
“I didn’t think I wanted to be an academic physician. Nothing had opened my eyes to that yet,” says Dr. Dranoff, an internationally known physician-scientist at the University of Arkansas for Medical Sciences (UAMS) in Little Rock. “The stuff about gastroenterology that seemed exciting to me as a resident was not hepatology.”
However, during a digestive diseases fellowship at Yale University Medical School in New Haven, a program with a strong tradition in hepatology, Dr. Dranoff began with a three-month inpatient liver service rotation. He cites “three wonderful, brilliant attending physicians” in the program for showing him the excitement of hepatology that he’d overlooked earlier. “I was hooked. I knew I was going to be a hepatologist.”
Among his mentors was former AASLD President Guadalupe “Lupe” Garcia-Tsao, MD, whose “consummate mastery of the field, from disease pathology to clinical manifestations, and a very good ability to devise practical and implementable interventions that actually help people” made strong impressions on him. He also cites Yale’s Michael Nathanson, MD, PhD, as an influential mentor. “With Mike, it was his supreme confidence, and a sense of really enjoying himself” that impressed him. Due to these mentors, Dr. Dranoff discovered the path to his current career. “Clinical medicine is a treat when it complements other academic activities.”
Victor Navarro, MD, Chair of Hepatology at Einstein Healthcare Network in Philadelphia, was another influence on Dr. Dranoff during his fellowship at Yale in his late 20s.
“He’s very confident, and he seemed to get a kick out of doing things in a really high-quality way. It seemed more fun than I expected it to be, and it has been that way for my whole career,” he says. “Hepatology is just really fun and challenging, and it rewards people who do their homework and learn.”
After opening his own laboratory and working closely with the leadership at Yale Liver Center, Dr. Dranoff was happy with the status quo. But in his late 30s, he was offered a position as a division director in Little Rock. He decided to go for it, moving from the Ivy League campus in New England to the Deep South.
“I thought I had the right combination of skills and personality to thrive as a division director,” he says. The attractions of the new position included “ the ability to build an entire division based on what I believe in and what I have learned, to recruit talented people, and to bring first-class liver care to an area which had not had it before.”
Dr. Dranoff settled in quickly in Little Rock, and says he enjoys the laid-back, friendly nature of this sophisticated city, as well as its easy navigability. “I don’t ever want to take two hours to drive to work ever again!” He recognizes that Little Rock is a prosperous city, a state capital, filled with educated professionals and many amenities, in the midst of a rural region where gastroenterologists are scarce, and many patients have to drive up to three hours for care.
“We would rather compete on behalf of academic hepatology. We compete for grants and limited resources, but it’s more important for us to feel good about the field itself.”
His clinical work focuses on the cholangiopathies, a set of conditions that affect bile duct cells, including primary sclerosing cholangitis and primary biliary cirrhosis. He also has a strong interest in cirrhosis and its complications, and his NIH-supported research explored cirrhosis and liver fibrosis. He also devotes time to act as a mentor to young fellow trainees, continuing the cycle of guidance and support that he experienced early in his career.
“What I get from them is probably more than they get from me. I share my enthusiasm with them as they move forward in their careers,” he says. “I am able to find out what someone at that stage of career is thinking, and that knowledge helps me be a better division director and leader. I learn the problems that they encounter and it shows me things we might avoid in the future.”
Academic hepatology is a small, close-knit field and a true community where physician-scientists encourage rather than compete with each other, says Dr. Dranoff. “We would rather compete on behalf of academic hepatology. We compete for grants and limited resources, but it’s more important for us to feel good about the field itself.”
Limited funding is the biggest challenge facing the field today, and the National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases may not be counted on to provide the consistent research funding that is needed, he says. “It’s a little scary, and it should scare people. But I hope this leads us to look at new approaches” to funding.
He’s been involved with the AASLD since the mid-‘90s, when he went to his first meeting in Chicago. The camaraderie he experienced with colleagues there “made it feel like a wonderful use of my time,” he says. “There’s really nobody doing exactly what I do, because ours is a fairly diverse organization. People have many different opinions, and it’s good that there’s not a lot of hegemony in academic hepatology. I expect us to continue to have that combination of values.”
AASLD offers great value to its members, including advocacy, he says. The association’s leaders and staff devote time and attention to members’ needs. He completed the AASLD Schering Advanced Fellowship in 2000-2001, and served for a few years as the Chair of the Liver Fibrosis Scientific Investigator Group.
Outside of work, Dr. Dranoff is an avid guitarist and guitar collector. His genres include blues, rock and roll, jazz and country, and he play mostly electric guitar. He loves his three Heritage guitars, made in Kalamazoo, Michigan. While he’s performed on stage in the past, his most recent gig was at his Little Rock temple, where he played guitar in a band at a Purimshpiel, a musical play to commemorate the Jewish holiday of Purim.
“I’m not a good singer or actor. But if people want me to play, I’ll do it, and I take it seriously,” he says. “If I didn’t have young kids, I’d probably play guitar more often. At least I’m not a drummer. There’s nothing lonelier than carrying a drum kit to the car at 2 a.m.”
Lucia Rivera‐Matos, Sarah Andrews, Sheila Eswaran – 26 May 2022
Julio A. Gutierrez, Leticia Z. Bresnahan, Elena Rios, Priya Wanchoo, Adelfo San Valentin, Margot Embree Fisher – 26 May 2022
Jeremy S. Nayagam, Aamir Nawaz, Katie Ramos, Matthew E. Cramp, Catriona Shaw, Sapna Shah, Deepak Joshi, Nigel Heaton, Abid Suddle – 26 May 2022
Yuanqing Lu, Liqun R. Wang, Jungnam Lee, Naweed S. Mohammad, Alek M. Aranyos, Calvin Gould, Nazli Khodayari, Regina A. Oshins, Craig G. Moneypenny, Mark L. Brantly – 26 May 2022 – Alpha‐1 antitrypsin (AAT) deficiency (AATD) is an inherited disease caused by mutations in the serpin family A member 1 (SERPINA1, also known as AAT) gene. The most common variant, PI*Z (Glu342Lys), causes accumulation of aberrantly folded AAT in the endoplasmic reticulum (ER) of hepatocytes that is associated with a toxic gain of function, hepatocellular injury, liver fibrosis, and hepatocellular carcinoma.
Lanjing Zhang, Grace L. Guo – 26 May 2022
Julio A. Gutierrez, Leticia Z. Bresnahan, Elena Rios, Priya Wanchoo, Adelfo San Valentin, Margot Embree Fisher – 26 May 2022
Lucia Rivera‐Matos, Sarah Andrews, Sheila Eswaran – 26 May 2022